SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-22-000095
Filing Date
2022-08-11
Accepted
2022-08-11 16:09:53
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20220630.htm   iXBRL 10-Q 1110251
2 EX-31.1 sum-ex311_20220630xduggan.htm EX-31.1 11886
3 EX-31.2 sum-ex312_20220630xzanganeh.htm EX-31.2 11965
4 EX-31.3 sum-ex313_20220630xdhingra.htm EX-31.3 11972
5 EX-32.1 sum-ex321_20220630x10q.htm EX-32.1 11151
  Complete submission text file 0001599298-22-000095.txt   5220787

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20220630.xsd EX-101.SCH 41556
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20220630_cal.xml EX-101.CAL 48206
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20220630_def.xml EX-101.DEF 158594
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20220630_lab.xml EX-101.LAB 445061
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20220630_pre.xml EX-101.PRE 318024
64 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20220630_htm.xml XML 766794
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 221155797
SIC: 2834 Pharmaceutical Preparations